THE CENTER FOR INTERVENTIONAL
VASCULAR THERAPY
New York-Presbyterian Hospital
Columbia University Medical Center
New york, U.S.A.
161 Ft. Washington Ave., 5th Floor
New York, NY 10032
U.S.A.
212.305.7060
|  |
|
| |
|
Quick links: |
| |
|
| |
About New York - Presbyterian Hospital
|
 | NewYork-Presbyterian Hospital is one of the most comprehensive university hospitals in the world, with leading specialists in every field of medicine. We are composed of two renowned |
|
|
medical centers, NewYork-Presbyterian Hospital/Columbia University Medical Center and New York-Presbyterian Hospital/Weill Cornell Medical Center, and we are affiliated with two Ivy League medical colleges, Columbia University College of Physicians & Surgeons and Weill Medical College of Cornell University.
In the spring of 2006, NewYork-Presbyterian Hospital/Columbia University Medical Center will break-ground on a six-level, 142,000-square-foot Heart Center. It will be one of the top heart hospitals in the world. The heart center has important features to enhance care; outstanding
|
specialists, non-surgical alternatives, science at the bedside, and convenient and efficient access to care. |
 |
|
| |
| |
The Center for Interventional Vascular Therapy
|
The Center for Interventional Vascular Therapy (CIVT), under the direction of Dr. Jeffrey Moses, demonstrates the commitment of NewYork-Presbyterian / Columbia to establishing a world-class center for the treatment cardiovascular disease. Patients with cardiovascular disease have access to a team of physicians who are practicing at the forefront of virtually every field of cardiovascular medicine. |
| |
| |
Clinical expertise and advanced technologies
|
The physicians affiliated with the Center for Interventional Vascular Therapy represent the most experienced group of coronary and endovascular interventionalists found anywhere in the world. Leaders in less invasive cardiovascular diagnosis and treatment approaches, they offer procedures that address all levels of medical complexity, including:
• Coronary angioplasty, stents, and drug-eluting stents
• Athero-ablative devices (atherectomy and lasers)
• Percutaneous coronary intervention (PCI) for acute myocardial infarction (MI)
• Carotid stents
• Structural heart disease therapy for patent foramen ovale (PFO) and atrial septal defect (ASD) closure
• Endovascular interventions for renal, aortic, ileofemoral and other peripheral vascular diseases
• New pharmacological agents for acute MI and PCI
• Gene and cell-based therapies for angiogenesis/myogenesis
• Non-surgical heart valve therapies
Our physicians perform a large volume of complicated coronary interventions, offering high-risk patients an array of procedures and treatment options that often will obviate the need for cardiac surgery.
Center physicians are skilled at diagnosing and treating difficult-to-detect congenital heart defects such as patent foramen ovale, an opening in the wall that separates the left and right atria of the heart that fails to close soon after birth. Many adults are unaware they have this condition until an acute medical episode, such as a stroke, occurs. Rather than repairing the opening surgically, a closure device can be inserted through a catheter that is inserted into an artery in the groin.
|
| |
| |
Integrated research initiatives
|
The Center for Interventional Vascular Therapy emphasizes high academic standards, clinical research and education under the aegis of the Cardiovascular Research Foundation and Columbia University Medical Center. An extraordinary team of healthcare professionals is devoted solely to the development of clinical research programs for our patients. All research efforts stress careful patient screening and patient safety. More than 30 clinical protocols are currently active; many involve second- or thirdgeneration devices, such as advanced drug-eluting stents, that have already been approved.
Researchers are pursuing new approaches to the treatment of restenosis (re-narrowing of arteries) and complex coronary lesions. They are developing a number of new imaging modalities that will allow the physician to understand the specific nature of a patient’s disease in order to assist with diagnosis, intra-procedural assessment, and post-treatment management.
New pharmacologic approaches to treating patients who have complex coronary disease with associated problems, such as diabetes, are also under study. Several unique protocols will focus on patients with end-stage aortic stenosis and mitral valve regurgitation who may benefit from innovative catheterbased valve therapies.
We are organizing a team of dedicated experts in the field of basic and clinical stem cell research, which in the future may help to grow new blood vessels (angiogenesis) or new heart muscle (myogenesis).
Other research efforts include coordinating and analyzing data from 60 clinical trials and maintaining a comprehensive prospective database for following and tracking patient outcomes. Our faculty has written more than 2,500 peer-reviewed abstracts, manuscripts and book chapters in cardiovascular publications, and our staff is currently editing a definitive textbook in interventional cardiology.
|
| |
| |
A commitment to education
|
The Center for Interventional Vascular Therapy is part of an academic medical center committed to physician training and continuing medical education. The cardiovascular subspecialty residency and fellowship training programs at NewYork-Presbyterian/Columbia are among the most highly sought after in the country, with programs that offer a broad range of training opportunities in a stimulating learning environment which is focused on clinical practice and research. The Center for Interventional Vascular Therapy also enriches the professional community through educational outreach efforts managed by the Cardiovascular Research Foundation. These efforts include the annual Transcatheter Cardiovascular Therapeutics symposium — the largest symposium in interventional vascular medicine in the world— with 60 educational events annually; and a web site in interventional cardiology (www.tctmd.com) with more than 70,000 subscribers.
|
| |
| |
CIVT Physicians
|
Jeffrey W. Moses, M.D., Director
Martin B. Leon, M.D., Associate Director
Gregg W. Stone, M.D., Director Research and Education
|
Mark A. Apfelbaum, M.D.
Michael B. Collins, M.D.
Nicola Corvaja, M.D.
William A. Gray, M.D.
Alexandra J. Lansky, M.D.
Issam Moussa, M.D.
Stanley J. Schneller, M.D.
Binoy Singh, M.D.
Robert Sommer, M.D.
Paul Teirstein, M.D.
Steven D. Wolff, M.D. |
Stephane Carlier, M.D., Ph.D.
Antonio Colombo,
M.D.
George D. Dangas, M.D., Ph.D.
Edward M. Kreps, M.D.
Ajay Kirtane, M.D.
Susheel K. Kodali, M.D.
Roxana Mehran, M.D.
LeRoy E. Rabbani, M.D.
Warren Sherman, M.D.
Varinder P. Singh, M.D.
Gurkan Taviloglu, M.D
Giora Weisz, M.D.
|
|
Fellows |
Abdolreza Agahtehrani, M.D.
Satya Atmakuri, M.D.
Neil Goyal, M.D.
|
Anuj Gupta, M.D.
Kotaro Obunai, M.D. |
|
|
| |
| |
Website links
|
| |
|
| Click here to access CIVT's website |
| |
|
|
| |
 |
|
